About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

378040 studies
in
220 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/14/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/14/2021.

Clinical Effectiveness of(VistaProof)in Comparison With ICDAS-II & Histological Validation for Detecting Occlusal Caries

Clinicaltrials.gov identifier NCT03940170

Recruitment Status Not yet recruiting

First Posted May 7, 2019

Last update posted May 7, 2019

Study Description

Brief summary:

a diagnostic accuracy study control trial is to be held to evaluate the Clinical performance of quantitative light fluorescence based device (Vistacam Proof) in comparison with the visual examination and histological validation in detection of initial pits and fissures caries

  • Condition or Disease:Light Fluorescence Device
  • Intervention/Treatment: Device: vistacam proof
    Other: ICDASII
    Procedure: fissurotomy
  • Phase: N/A
Detailed Description

N/A

Study Design
  • Study Type: Observational
  • Estimated Enrollment: 24 participants
  • Observational Model: Other
  • Time Perspective: Prospective
  • Official Title: Clinical Effectiveness of Quantitative Light Fluorescence Based Device (Vistacam Proof) in Comparison With ICDAS-II and Histological Validation in Detection of Initial Pits and Fissures Caries:: Diagnostic Accuracy Study
  • Estimated Study Start Date: June 2019
  • Estimated Primary Completion Date: August 2020
  • Estimated Study Completion Date: September 2020
Groups and Cohorts
Groups/Cohorts Intervention/treatment
: Fissurotomy
Device: vistacam proof
Light fluorescence device

Other: ICDASII
visual examination

Procedure: fissurotomy
histological validation
: vistacam
Device: vistacam proof
Light fluorescence device
: ICDAS II
Other: ICDASII
visual examination
Outcome Measures
  • Primary Outcome Measures: 1. pits and fissure caries [ Time Frame: through study completion, an average of 1 year ]
    occlusal pits and fissure caries in posterior teeth non-cavitated
Eligibility Criteria
  • Ages Eligible for Study: 15 to 50 Years (Child, Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers:
  • Sampling Method: Probability Sample
  • Study Population: Egyptian population
Criteria

Inclusion Criteria:

- Patients aged from 15 to 50 years.

- Patient at least has one posterior pits and fissure occlusal caries.

- No gender restriction

- Co-operative patients who signed the informed consent.

- Good general health

- Acceptable oral health

Exclusion Criteria:

- Pregnancy.

- Disabilities.

- Systemic disease or severe medical complications.

- Allergic history concerning methacrylate.

- Rampant caries.

Contacts and Locations
Contacts

Contact: Mohamed sa EL-sayed, Assistant lecturer 01002071085 samodaser@gmail.com

Contact: Amr Mahmoud Edrees, Assistant lecturer 002-01008221121 amr.edrees@gmail.com

Locations
Sponsors and Collaborators

Mohamed samy El-sayed

More Information
  • Responsible Party: Mohamed samy El-sayed
  • ClinicalTrials.gov Identifier: NCT03940170 History of Changes
  • Other Study ID Numbers: 2222
  • First Posted: May 7, 2019 Key Record Dates
  • Last Update Posted: May 7, 2019
  • Last Verified: May 2019
  • Individual Participant
    Data (IPD) Sharing
    Statement:
  • Plan to Share IPD: Undecided
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: Yes
  • Product Manufactured in and Exported from the U.S.: Yes